Skip to main content
Fig. 2 | Molecular Neurodegeneration

Fig. 2

From: The informed road map to prevention of Alzheimer Disease: A call to arms

Fig. 2

Alzheimer’s disease prevention trials and targets: Prevention trials and target agents for treatment of Alzheimer’s disease in 2020 (from ClinicalTrials.gov as of August 24, 2020). The inner ring shows prevention trials agents; the outer ring presents lifestyle prevention trials. AD therapeutics interventions were classified according with the terminology of the Common Alzheimer’s and Related Dementias Research Ontology (CADRO). Lifestyle interventions (N = 18), Drug Targets (N = 37)

Back to article page